Your browser doesn't support javascript.
loading
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.
Babjuk, Marko; Burger, Maximilian; Compérat, Eva M; Gontero, Paolo; Mostafid, A Hugh; Palou, Joan; van Rhijn, Bas W G; Rouprêt, Morgan; Shariat, Shahrokh F; Sylvester, Richard; Zigeuner, Richard; Capoun, Otakar; Cohen, Daniel; Escrig, José Luis Dominguez; Hernández, Virginia; Peyronnet, Benoit; Seisen, Thomas; Soukup, Viktor.
Afiliação
  • Babjuk M; Department of Urology, 2nd Faculty of Medicine, Hospital Motol, Charles University, Prague, Czech Republic; Department of Urology, Medical University of Vienna, Vienna, Austria. Electronic address: Marek.Babjuk@fnmotol.cz.
  • Burger M; Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Regensburg, Germany.
  • Compérat EM; Department of Pathology, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, UPMC Paris VI, Paris, France.
  • Gontero P; Division of Urology, Molinette Hospital, University of Studies of Torino, Torino, Italy.
  • Mostafid AH; Department of Urology, Royal Surrey County Hospital, Guildford, Surrey, UK.
  • Palou J; Department of Urology, Fundació Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • van Rhijn BWG; Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Regensburg, Germany; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Rouprêt M; Urology Department, Sorbonne Université, GRC n°5, ONCOTYPE-URO, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.
  • Shariat SF; Department of Urology, 2nd Faculty of Medicine, Hospital Motol, Charles University, Prague, Czech Republic; Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York, NY, USA; Department of Urology, University of Texas Southw
  • Sylvester R; European Association of Urology Guidelines Office, Brussels, Belgium.
  • Zigeuner R; Department of Urology, Medical University of Graz, Graz, Austria.
  • Capoun O; Department of Urology, General University Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Cohen D; Department of Urology, Royal Free London NHS Foundation Trust, London, UK.
  • Escrig JLD; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
  • Hernández V; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
  • Peyronnet B; Department of Urology, University of Rennes, Rennes, France.
  • Seisen T; Urology Department, Sorbonne Université, GRC n°5, ONCOTYPE-URO, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.
  • Soukup V; Department of Urology, General University Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic.
Eur Urol ; 76(5): 639-657, 2019 Nov.
Article em En | MEDLINE | ID: mdl-31443960

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urologia / Administração dos Cuidados ao Paciente / Neoplasias da Bexiga Urinária / Guias de Prática Clínica como Assunto Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Urologia / Administração dos Cuidados ao Paciente / Neoplasias da Bexiga Urinária / Guias de Prática Clínica como Assunto Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article